Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
September 5, 2007
Synthesis of 3-O-methylviridicatin analogues with improved anti-TNF-alpha properties
Nigel Ribeiro, Helena Tabaka, Jean Peluso, et al.
Plos One
|
November 9, 2011
Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27
Yohann Bernard, Nigel Ribeiro, Frédéric Thuaud, et al.
Chemistry & Biology
|
March 24, 2007
"Primitive" membrane from polyprenyl phosphates and polyprenyl alcohols
Stéphane Streiff, Nigel Ribeiro, Zhengyan Wu, et al.
European Journal of Medicinal Chemistry
|
May 20, 2014
Benzofuran derivatives as anticancer inhibitors of mTOR signaling
Christophe Salomé, Nigel Ribeiro, Thierry Chavagnan, et al.
Plos One
|
April 2, 2015
Discovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1
Adeline Gasser, Simone Brogi, Kyoji Urayama, et al.
European Journal of Medicinal Chemistry
|
January 22, 2014
Benzofuran derivatives as a novel class of inhibitors of mTOR signaling
Christophe Salomé, Vanessa Narbonne, Nigel Ribeiro, et al.
Chemistry & Biodiversity
|
December 29, 2006
A novel type of membrane based on cholesteryl phosphocholine, cholesteryl phosphate, or sitosteryl phosphate, and dimyristoylglycerol
Mari Gotoh, Nigel Ribeiro, Bernard Michels, et al.
Chemistry & Biodiversity
|
December 29, 2006
Membrane properties of branched polyprenyl phosphates, postulated as primitive membrane constituents
Mari Gotoh, Ayako Miki, Hajime Nagano, et al.
Journal of Medicinal Chemistry
|
October 18, 2012
Flavaglines as potent anticancer and cytoprotective agents
Nigel Ribeiro, Frédéric Thuaud, Yohann Bernard, et al.
Chemistry & Biology
|
September 25, 2012
The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2
Gernot Polier, Jennifer Neumann, Frédéric Thuaud, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Bioorganic & Medicinal Chemistry Letters
|
September 5, 2007
Synthesis of 3-O-methylviridicatin analogues with improved anti-TNF-alpha properties
Nigel Ribeiro, Helena Tabaka, Jean Peluso, et al.
Plos One
|
November 9, 2011
Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27
Yohann Bernard, Nigel Ribeiro, Frédéric Thuaud, et al.
Chemistry & Biology
|
March 24, 2007
"Primitive" membrane from polyprenyl phosphates and polyprenyl alcohols
Stéphane Streiff, Nigel Ribeiro, Zhengyan Wu, et al.
European Journal of Medicinal Chemistry
|
May 20, 2014
Benzofuran derivatives as anticancer inhibitors of mTOR signaling
Christophe Salomé, Nigel Ribeiro, Thierry Chavagnan, et al.
Plos One
|
April 2, 2015
Discovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1
Adeline Gasser, Simone Brogi, Kyoji Urayama, et al.
European Journal of Medicinal Chemistry
|
January 22, 2014
Benzofuran derivatives as a novel class of inhibitors of mTOR signaling
Christophe Salomé, Vanessa Narbonne, Nigel Ribeiro, et al.
Chemistry & Biodiversity
|
December 29, 2006
A novel type of membrane based on cholesteryl phosphocholine, cholesteryl phosphate, or sitosteryl phosphate, and dimyristoylglycerol
Mari Gotoh, Nigel Ribeiro, Bernard Michels, et al.
Chemistry & Biodiversity
|
December 29, 2006
Membrane properties of branched polyprenyl phosphates, postulated as primitive membrane constituents
Mari Gotoh, Ayako Miki, Hajime Nagano, et al.
Journal of Medicinal Chemistry
|
October 18, 2012
Flavaglines as potent anticancer and cytoprotective agents
Nigel Ribeiro, Frédéric Thuaud, Yohann Bernard, et al.
Chemistry & Biology
|
September 25, 2012
The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2
Gernot Polier, Jennifer Neumann, Frédéric Thuaud, et al.
Page
of 3